Women Health and Psychological Functioning in Different Periods of Life: Evaluation of Nursing Approach

World Health Organization describes health as the state of being completely fine corporally, socially and psychologically. The state of being completely fine which is indicated in this description of health has been criticised by many scientists and with the idea that noone shall ever realise tha state of being completely fine corporally and psychologically, it was emphasized that individuals could be evaluated to be “healthy” as long as they are productive. Starting from the intrauterine period, woman passes through different periods such as childhood, adolescence, adulthood, elderliness and she experiences some physical, psychological and social differences in each of these periods within the frame of life cycle. While these differences influence productivities and life qualities of women negatively, they also make them more inclined to psychiatric illnesses. Therefore, psychological problems are more common among women and they last longer. Considering the fact that among the medical personnel, it is the nurses who spend time with patients during the phases of diagnosis, treatment and rehabilitation the most, it could be said that nurses have a significant role in intervening in problems that affect the psychological health of woman. The nurse has responsibilities such as determining the problem the woman goes through, providing protective care, getting an early diagnosis, making the convenient remedial intervention and consigning, when necessary. In this article, significant woman health problems that could be experienced starting from the intrauterine life until the end of life by woman, the effects of this problem to the psychological health of the woman and nursing approaches in view of these problems are discussed

Mikroskopie und Spektroskopie von Bitumen

Abweichender Titel nach Übersetzung der Verfasserin/des Verfassers6

Atypical Hemolytic Uremic Syndrome in Children Aged < 2 Years

Background: There are limited data on infants with atypical hemolytic uremic syndrome (aHUS). The aim of this study was to determine the clinical and laboratory features, and to evaluate treatment modalities and outcomes in infants with aHUS. Materials and Methods: Relevant data on patients with onset of aHUS at age <2 years were obtained from the Turkish Pediatric aHUS Registry. Results: Among the 146 patients included in the Registry, 53 (36%) (23 male and 30 female) were enrolled for the study. Age at disease onset was <= 1 year in 29 of the patients. In all, 21 (40%) of the patients developed neurological symptoms. Disease-causing muta tions were noted in 14 (36%) of the 39 patients in which genetic analysis was performed. Plasma therapy was performed in 42 (79%) patients; eculizumab therapy was administered to treat the first episode of aHUS in 33 (62%) patients and in 5 patients as the first- line therapy. In total, 38 (72%) patients received renal replacement therapy (RRT), 3 (6%) died due to acute illness, and 4 (8%) were discharged from hospital with RRT. Follow-up visit data were available for 46 patients and the median duration was 23 months (range 3-129 months). End-stage renal disease developed only in 1 patient. Proteinuria and hypertension persisted in 17 (37%) and 20 patients (44%) respectively. Eculizumab treatment was continued in 25 of the 39 patients during the follow-up period. Conclusion:One-third of the aHUS patients had disease onset during infancy. The prognosis of this life-threatening disease seems to get better with improved treatment modalities. (C) 2018 S. Karger AG, Base